Implementing Genomic Clinical Decision Support for Drug-Based Precision Medicine
- PMID: 28109071
- PMCID: PMC5351408
- DOI: 10.1002/psp4.12173
Implementing Genomic Clinical Decision Support for Drug-Based Precision Medicine
Abstract
The explosive growth of patient-specific genomic information relevant to drug therapy will continue to be a defining characteristic of biomedical research. To implement drug-based personalized medicine (PM) for patients, clinicians need actionable information incorporated into electronic health records (EHRs). New clinical decision support (CDS) methods and informatics infrastructure are required in order to comprehensively integrate, interpret, deliver, and apply the full range of genomic data for each patient.
© 2017 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.
References
-
- AHRQ . Section 2: Overview of CDS Five Rights. <https://healthit.ahrq.gov/ahrq-funded-projects/clinical-decision-support.... Accessed 1 December 2016.
-
- Welch, B.M. , Eilbeck, K. , Del Fiol, G. , Meyer, L.J. & Kawamoto, K. Technical desiderata for the integration of genomic data with clinical decision support. J. Biomed. Inform. 51, 3–7 (2014). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources